🇺🇸 MRK — Merck & Co., Inc.

Salud Compra
← Volver

Precio actual

146,73 USD

Máx. histórico

156,45

73 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-6,21%

Rango 52 semanas

85,24 – 156,92

Variación hoy

-0,14%

Cierre anterior

146,94

Rango de hoy

142,80 – 147,48

Volumen hoy

7.462.267

Peor caída histórica

-68,62%

28/12/2000 → 09/03/2009

Recuperado en 1796 días

Volatilidad anualizada ⓘ

25,43%

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
148,21 (puede no estar actualizado)
Dividend yield
2,31% (puede no estar actualizado)
Precio objetivo analistas
161,53 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 7 horas
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,4000 USD · Yield: 2,32%
Fecha de pago Importe por participación
15/09/2026 0,8500 USD
15/06/2026 0,8500 USD
16/03/2026 0,8500 USD
15/12/2025 0,8500 USD
15/09/2025 0,8100 USD
16/06/2025 0,8100 USD
17/03/2025 0,8100 USD
16/12/2024 0,8100 USD
16/09/2024 0,7700 USD
17/06/2024 0,7700 USD
14/03/2024 0,7700 USD
14/12/2023 0,7700 USD
14/09/2023 0,7300 USD
14/06/2023 0,7300 USD
14/03/2023 0,7300 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
02/03/2015 55,86 56,19 55,61 55,90 +0,07% 1,04% 10.131.226
27/02/2015 56,19 56,36 55,81 55,86 -0,71% 0,97% 13.686.775
26/02/2015 55,97 56,44 55,97 56,26 +0,80% 0,84% 12.040.577
25/02/2015 55,78 56,27 55,40 55,81 +0,22% 1,56% 8.861.050
24/02/2015 55,81 55,89 55,39 55,69 +0,10% 0,89% 8.084.377
23/02/2015 55,72 55,98 55,51 55,63 -0,09% 0,86% 9.002.215
20/02/2015 55,49 55,80 55,09 55,68 +0,09% 1,29% 12.161.830
19/02/2015 56,15 56,29 55,16 55,63 -0,85% 2,01% 10.308.338
18/02/2015 55,98 56,31 55,56 56,11 +0,02% 1,33% 11.039.842
17/02/2015 56,05 56,27 56,01 56,10 -0,03% 0,46% 10.676.290
13/02/2015 56,20 56,24 55,93 56,12 -0,12% 0,56% 8.278.466
12/02/2015 56,30 56,40 55,91 56,18 +0,24% 0,88% 7.553.670
11/02/2015 56,07 56,26 55,73 56,05 -0,19% 0,95% 10.987.127
10/02/2015 56,30 56,62 56,08 56,15 +0,89% 0,97% 9.997.291
09/02/2015 55,96 56,30 55,28 55,66 -0,78% 1,82% 10.494.777
06/02/2015 56,39 57,03 55,90 56,10 -0,64% 2,01% 10.338.310
05/02/2015 56,56 56,63 55,83 56,46 +0,20% 1,42% 13.268.099
04/02/2015 57,22 57,25 55,67 56,35 -3,23% 2,77% 20.380.142
03/02/2015 58,10 58,26 57,19 58,23 +0,23% 1,84% 12.028.420
02/02/2015 57,73 58,14 57,04 58,09 +1,00% 1,90% 9.711.502
30/01/2015 58,71 59,09 57,28 57,52 -2,92% 3,09% 12.667.071
29/01/2015 58,72 59,30 57,98 59,25 +1,04% 2,26% 9.527.682
28/01/2015 59,94 60,08 58,51 58,64 -1,77% 2,61% 9.293.769
27/01/2015 60,00 60,13 59,28 59,69 -0,41% 1,42% 8.347.425
26/01/2015 59,71 60,10 59,27 59,94 +0,53% 1,37% 7.036.901
23/01/2015 59,60 60,11 59,55 59,63 -0,16% 0,94% 6.528.097
22/01/2015 59,41 59,84 58,71 59,72 +0,69% 1,90% 8.902.131
21/01/2015 59,56 59,90 59,24 59,31 -0,72% 1,12% 9.517.307
20/01/2015 59,84 60,40 59,05 59,74 -0,67% 2,26% 13.734.983
16/01/2015 59,03 60,27 58,71 60,14 +1,86% 2,64% 11.917.018